Biocon (NSE:BIOCON) Other Long Term Assets : ₹20,394 Mil (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Biocon Other Long Term Assets?

Biocon's other long-term assets for the quarter that ended in Mar. 2025 was ₹20,394 Mil.

Biocon's quarterly other long-term assets declined from Sep. 2024 (₹28,286 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹20,394 Mil).

Biocon's annual other long-term assets declined from Mar. 2023 (₹29,241 Mil) to Mar. 2024 (₹22,546 Mil) and declined from Mar. 2024 (₹22,546 Mil) to Mar. 2025 (₹20,394 Mil).

Biocon Other Long Term Assets Historical Data

The historical data trend for Biocon's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon Other Long Term Assets Chart

Biocon Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Other Long Term Assets

Get a 7-Day Free Trial

17,008.00

12,811.00

29,241.00

22,546.00

20,394.00

Biocon Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															22,546.00	-	28,286.00	-	20,394.00

Biocon Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Biocon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (NSE:BIOCON) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

532523:India

Address

20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560100

Website

https://www.biocon.com

Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Biosimilars which derives maximum revenue, Generics, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene. Geographically, the company generates a majority of its revenue from its customers located in India and the rest from Brazil, Singapore, and the rest of the world.

Biocon Headlines

No Headlines